Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials
Despite an overall good prognosis, low RF-CL patients have reduced risk of myocardial infarction or death when allocated to coronary CTA vs. usual care. Risk is similar in patients with very-low and moderate/high likelihood.
Authors
- Samuel Emil Schmidt (ORCID: https://orcid.org/0000-0002-0917-634X)
- Simon Winther (ORCID: https://orcid.org/0000-0001-8872-3681)
- Christiaan J. Vrints (ORCID: https://orcid.org/0000-0002-9263-5702)
- Morten Bøttcher (ORCID: https://orcid.org/0000-0002-2116-2370)
- Michelle C. Williams (ORCID: https://orcid.org/0000-0003-3556-2428)
- Borek Foldyna (ORCID: https://orcid.org/0000-0002-2466-4827)
- Pamela S. Douglas (ORCID: https://orcid.org/0000-0001-9876-4049)
- Juhani Knuuti (ORCID: https://orcid.org/0000-0003-3156-9593)
- David E. Newby (ORCID: https://orcid.org/0000-0001-7971-4628)
- Laust Dupont Rasmussen (ORCID: https://orcid.org/0000-0002-2790-2608)
Institutions
- Harvard University (US)
- University of Antwerp (BE)
- University of Turku (FI)
- Duke University (US)
- Aalborg University Hospital (DK)
- Turku University Hospital (FI)
- British Heart Foundation (GB)
- Massachusetts General Hospital (US)
- Clinical Research Institute (US)
- Antwerp University Hospital (BE)
- Turku PET Centre (FI)
- Aalborg University (DK)
- University of Edinburgh (GB)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1093/eurheartj/ehae742
- Citations
- 12
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.85
Funders
- Israel Cancer Research Fund
- Hjerteforeningen
- Foundation for Cardiovascular Research
- British Heart Foundation
- Academy of Finland
- Novo Nordisk
- Sydäntutkimussäätiö
- Novo Nordisk Fonden
- Turun Yliopistollinen Keskussairaala